Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

Ultratech Cement - Q3FY21 First Cut - ICICI Direct

Posted On: 2021-01-24 20:22:09 (Time Zone: Arizona, USA)

(CMP: Rs. 5,535; Mcap: Rs. 1,59,755 crore)

Ultratech Cement reported healthy set of numbers for Q3FY21. Better than expected sales volumes along with reduced power costs helped the company to report better operating results.

Q3FY21 Earnings Summary

- Standalone revenues for the quarter stood at Rs. 11,831 crores (vs. I-Direct est: Rs. 11,097 crore). Sales volume remained ahead of our estimates at 22.8MT (up 14.1% YoY, 18.8% QoQ) while the realisations remained marginally above our estimates at 5,184/t (vs I-direct est: 5,111/t). It increased by 3.9% YoY but remained flat QoQ.

- Capacity utilization improved to 80% vs 73% last year. In terms of regions, East operated with 100% capacity utilization while utilsaitons levels in South remained at 70%. Rest all regions like North, West and Central operated with average of 80% capacity

- On the profitability front, EBITDA margins expanded by 700bps YoY to 24.9% that remained ahead of I-direct estimated EBITDA margins of 22.6%. Better asset utilisations and use of low cost fuel inventory kept the cost of production lower by 5% YoY on per tonne basis that helped the company to achieve better margins. The company has mentioned that the full impact of higher petcoke prices would get reflected in numbers from Q1FY22 onwards.

- On absolute basis, the company reported EBITDA of Rs. 2,944 crore (up 64.9% YoY) vs. I-direct estimates of Rs. 2,509 crore while EBITDA/t for the quarter stood at Rs. 1,290/t (vs I-direct est of Rs. 1,155/t). PAT growth of 141% YoY to Rs. 1,550 crore is mainly attributable to improved sales volumes along with reduced costs.

- On the leverage front, the company has successfully reduced its Net Debt / EBITDA ratio to 0.73x from 1.74x last year and 1.1x last quarter. On absolute basis, the net debt for the year is reduced from Rs. 12,132 crore in Sep-20 to Rs. 9,436 crore as of Dec-20. The board has approved fund raising of Rs. 3000 crore to mainly take an advantage of interest arbitrage opportunities.

- On the recent announcement of entering into paint business by Promoter Grasim Industries, the company has clarified that it will continue to focus on the cement business only. However, there can be a possibility of cross selling opportunities depending upon the situation.

The Company's strong quarterly performance is on the back of operational efficiencies and its ability to serve all India markets. With prudent working capital management, and overall efficient operations, the company has shaved off Rs. 7,424 crore of net debt in the first nine months of this fiscal year. On the M&A front, the 14.6MT cement plants acquired during the previous financial year have been well integrated and operating with capacity utilisations of over 80%. The work on the Company's 3.4MT cement capacity addition in Odisha, Bihar and West Bengal has picked up pace and are expected to get commissioned during FY22E, in a phased manner. With strong rural growth, revival in manufacturing and govt backed high infrastructure push, we believe, Ultratech is well poised to capture the growth along with its timely expansion plans. We continue to remain positive on the company.

We would be coming out with a detailed report soon.

Shares of ULTRATECH CEMENT LTD. was last trading in BSE at Rs.5592 as compared to the previous close of Rs. 5543.3. The total number of shares traded during the day was 11099 in over 2233 trades.

The stock hit an intraday high of Rs. 5592.7 and intraday low of 5474. The net turnover during the day was Rs. 61485517.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Easy Trip Planners Ltd. - IPO - Strong Financials - Reliance Securities

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020